- Home
- GPRE vs NVCT Comparison
GPRE vs NVCT Comparison
Compare GPRE & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPRE | NVCT |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.2M | 721.2M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GPRE | NVCT |
|---|---|---|
| Price | $15.60 | $19.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $12.57 | $10.00 |
| AVG Volume (30 Days) | ★ 1.4M | 453.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $2,091,680,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.85 | N/A |
| P/E Ratio | $37.76 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $5.55 |
| 52 Week High | $18.94 | $29.28 |
Technical Indicators
Market Signals| Indicator | GPRE | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 53.16 | 57.70 |
| Support Level | $14.31 | $6.93 |
| Resistance Level | $15.64 | N/A |
| Average True Range (ATR) | 0.70 | 2.68 |
| MACD | 0.16 | 0.36 |
| Stochastic Oscillator | 67.50 | 49.51 |
Price Performance
Historical ComparisonAbout GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.